The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
Open accessAbstract
In recent studies we demonstrated that systemic levels of protein-bound nitrotyrosine (NO 2 Tyr) and myeloperoxidase (MPO), a protein that catalyzes generation of nitrating oxidants, serve as independent predictors of atherosclerotic risk, burden, and incident cardiac events.We now show both that apolipoprotein A-I (apoA-I), the primary protein constituent of HDL, is a selective target for MPO-catalyzed nitration and chlorination in vivo and that MPO-catalyzed oxidation of HDL and apoA-I results in selective inhibition in ABCA1-dependent cholesterol efflux from macrophages.Dramatic selective enrichment in NO 2 Tyr and chlorotyrosine (ClTyr) content within apoA-I recovered from serum and human atherosclerotic lesions is noted, and analysis of serum from sequential subjects demonstrates that the NO 2 Tyr and ClTyr contents of apoA-I are markedly higher in individuals with cardiovascular disease (CVD).Analysis of circulating HDL further reveals that higher NO 2 Tyr and ClTyr contents of the lipoprotein are each significantly associated with diminished ABCA1-dependent cholesterol efflux capacity of the lipoprotein.MPO as a likely mechanism for oxidative modification of apoA-I in vivo is apparently facilitated by MPO binding to apoA-I, as revealed by cross-immunoprecipitation studies in plasma, recovery of MPO within HDL-like particles isolated from human atheroma, and identification of a probable contact site between the apoA-I moiety of HDL and MPO.To our knowledge, the present results provide the first direct evidence for apoA-I as a selective target for MPO-catalyzed oxidative modification in human atheroma.They also suggest a potential mechanism for MPO-dependent generation of a proatherogenic dysfunctional form of HDL in vivo.that promote oxidative damage, cell injury, and conversion of LDL, the major carrier of cholesterol in plasma, into an atherogenic form (9, 14).Protein-bound nitrotyrosine (NO 2 Tyr), a posttranslational modification specific for protein oxidation by NO-derived oxidants (15-20), is markedly enriched within human atheroma (8, 21).Further, recent clinical studies demonstrate that systemic levels of protein-bound NO 2 Tyr serve as an independent predictor of atherosclerotic risk and burden in subjects and are modulated by known CVD risk-reducing therapies such as statins (10,22).Few studies to date have focused on defining the molecular targets of nitration in subjects with CVD, the attendant functional alterations, and the enzymatic participants in nitration.One potential enzymatic source for generation of NO-derived oxidants within human atheroma is the heme protein myeloperoxidase (MPO).MPO utilizes hydrogen peroxide (H 2 O 2 ) and a variety of low-molecular weight organic and inorganic substances as substrates to form reactive oxidant species capable of promoting protein halogenation, nitration, and oxidative cross-linking (4, 5).For example, MPO directly utilizes both NO (23) and the NO metabolite nitrite (NO 2 -) as substrates in vitro (17-19, 24) and participatesThe Journal of Clinical Investigation http://www.jci.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
HATCH, F. T., & LEES, R. S. (1968) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,234
Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,123
Vivekananthan, D. P., Penn, M. S., Sapp, S. K., Hsu, A., & Topol, E. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13637-9 · Cited by 1,083
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M.-L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,070
Self-citationMyeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,013
Zhang, Z., & Smith, D. L. (1993) · Protein Science · doi:10.1002/pro.5560020404 · Cited by 1,012
[23] Oxidative chemistry of peroxynitrite
Beckman, J. S., Chen, J., Ischiropoulos, H., & Crow, J. P. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33026-3 · Cited by 973
Self-citationNelson, D. P., & Kiesow, L. A. (1972) · Analytical Biochemistry · doi:10.1016/0003-2697(72)90451-4 · Cited by 925
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Self-citationFormation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
van der Vliet, A., Eiserich, J. P., Halliwell, B., & Cross, C. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7617 · Cited by 780
MacMillan-Crow, L. A., Crow, J. P., Kerby, J. D., Beckman, J. S., & Thompson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11853 · Cited by 772
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J., Vaughan, A. M., & Oram, J. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8119 · Cited by 724
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Protein Sequencing and Identification Using Tandem Mass Spectrometry
Kinter, M., & Sherman, N. E. (2000) · Wiley eBooks · doi:10.1002/0471721980 · Cited by 655
Self-citationMyeloperoxidase-generated oxidants and atherosclerosis
Podrez, E. A., Abu-Soud, H. M., & Hazen, S. L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00229-x · Cited by 605
Self-citationHDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Ansell, B. J., Navab, M., Hama, S., Kamranpour, N., Fonarow, G., Hough, G., Rahmani, S., Mottahedeh, R., Dave, R., Reddy, S. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103624.14436.4b · Cited by 590
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Self-citationIgnarro, L. J., Napoli, C., & Loscalzo, J. (2002) · Circulation Research · doi:10.1161/hh0102.102330 · Cited by 491
Brennan, M.-L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, C., Narine, L., Lenkiewicz, E., Borchers, M. T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112400200 · Cited by 486
Self-citationSteinberg, D., & Witztum, J. L. (2002) · Circulation · doi:10.1161/01.cir.0000014762.06201.06 · Cited by 471
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1675 · Cited by 464 · cited 4×
“Serum levels of protein-bound NO2Tyr serve as a predictor of atherosclerotic risk and burden in subjects (10), raising the question of whether nitration of specific proteins might contribute to the atherosclerotic process.”
BackgroundInfluentialSelf-citationLeeuwenburgh, C., Hardy, M. M., Hazen, S. L., Wagner, P., Oh-ishi, S., Steinbrecher, U. P., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1433 · Cited by 462
Self-citationPryor, W. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00224-5 · Cited by 451
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
Navab, M., Berliner, J. A., Subbanagounder, G., Hama, S., Lusis, A. J., Castellani, L. W., Reddy, S., Shih, D., Shi, W., Watson, A. D., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.481 · Cited by 442
Zhang, R., Brennan, M.-L., Shen, Z., MacPherson, J. C., Schmitt, D., Molenda, C. E., & Hazen, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209124200 · Cited by 432 · cited 1×
“org Volume 114 Number 4 August 2004 of significant FFAs by HPLC with on-line tandem MS analysis (25).”
MethodSelf-citationFrancis, G. A., Knopp, R. H., & Oram, J. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118082 · Cited by 424
Vitamin C-Induced Decomposition of Lipid Hydroperoxides to Endogenous Genotoxins
Lee, S. H., Oe, T., & Blair, I. A. (2001) · Science · doi:10.1126/science.1059501 · Cited by 414
Thiocyanate and chloride as competing substrates for myeloperoxidase
van DALEN, J. C., WHITEHOUSE, W. M., WINTERBOURN, C. C., & KETTLE, J. A. (1997) · Biochemical Journal · doi:10.1042/bj3270487 · Cited by 406
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Shishehbor, M. H., Brennan, M.-L., Aviles, R. J., Fu, X., Penn, M. S., Sprecher, D. L., & Hazen, S. L. (2003) · Circulation · doi:10.1161/01.cir.0000080895.05158.8b · Cited by 405
Self-citationNitric Oxide Is a Physiological Substrate for Mammalian Peroxidases
Abu-Soud, H. M., & Hazen, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.48.37524 · Cited by 398
Self-citationIncreased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages
Aiello, R. J., Brees, D., Bourassa, P.-A., Royer, L., Lindsey, S., Coskran, T., Haghpassand, M., & Francone, O. L. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000014804.35824.da · Cited by 390
Endothelial function and coronary artery disease
Kinlay, S., Libby, P., & Ganz, P. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00003 · Cited by 384
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M.-L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 365
Self-citationNavab, M., Hama, S. Y., Cooke, C. J., Anantharamaiah, G. M., Chaddha, M., Jin, L., Subbanagounder, G., Faull, K. F., Reddy, S. T., Miller, N. E., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33461-1 · Cited by 362
Nitric oxide: discovery and impact on clinical medicine
Moncada, S. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909200402 · Cited by 337
Savenkova, M. L., Mueller, D. M., & Heinecke, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32005-7 · Cited by 335
Navab, M., Hama, S. Y., Hough, G. P., Subbanagounder, G., Reddy, S. T., & Fogelman, A. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31582-0 · Cited by 334
Baldus, S., Eiserich, J. P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C. R., Bullard, D. C., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12617 · Cited by 333
Self-citationScavenger Receptors, Oxidized LDL, and Atherosclerosis
BOULLIER, A., BIRD, D. A., CHANG, M., DENNIS, E. A., FRIEDMAN, P., GILLOTTE‐TAYLOR, K., HÖRKKÖ, S., PALINSKI, W., QUEHENBERGER, O., SHAW, P., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03943.x · Cited by 330
Increased atherosclerosis in myeloperoxidase-deficient mice
Brennan, M.-L., Anderson, M. M., Shih, D. M., Qu, X.-D., Wang, X., Mehta, A. C., Lim, L. L., Shi, W., Hazen, S. L., Jacob, J. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci8797 · Cited by 323
Self-citationUpston, J. M., Terentis, A. C., & Stocker, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9.977 · Cited by 300
MacPherson, J. C., Comhair, S. A. A., Erzurum, S. C., Klein, D. F., Lipscomb, M. F., Kavuru, M. S., Samoszuk, M. K., & Hazen, S. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5763 · Cited by 281
Self-citationGraham, A., Hogg, N., Kalyanaraman, B., O'Leary, V., Darley-Usmar, V., & Moncada, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80269-z · Cited by 278
Effects of Vitamin E on Lipid Peroxidation in Healthy Persons
Meagher, E. A. (2001) · JAMA · doi:10.1001/jama.285.9.1178 · Cited by 270
Eosinophil peroxidase nitrates protein tyrosyl residues
Wu, W., Chen, Y., & Hazen, S. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25933 · Cited by 265
Self-citationIncreased ABCA1 activity protects against atherosclerosis
Singaraja, R. R., Fievet, C., Castro, G., James, E. R., Hennuyer, N., Clee, S. M., Bissada, N., Choy, J. C., Fruchart, J.-C., McManus, B. M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15748 · Cited by 250
Consequences of Total and Subtotal Myeloperoxidase Deficiency: Risk or Benefit ?
Kutter, D., Devaquet, P., Vanderstocken, G., Paulus, J. M., Marchal, V., & Gothot, A. (2000) · Acta Haematologica · doi:10.1159/000041062 · Cited by 250
Nagano, Y., Arai, H., & Kita, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6457 · Cited by 245
Takahashi, Y., & Smith, J. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11358 · Cited by 236
Self-citationMechanism of Reaction of Myeloperoxidase with Nitrite
Burner, U., Furtmüller, P. G., Kettle, A. J., Koppenol, W. H., & Obinger, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000181200 · Cited by 220
Nikpoor, B., Turecki, G., Fournier, C., Théroux, P., & Rouleau, G. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116769 · Cited by 209
Remaley, A. T., Schumacher, U. K., Stonik, J. A., Farsi, B. D., Nazih, H., & Brewer, H. B. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1813 · Cited by 204
Myeloperoxidase produces nitrating oxidants in vivo
Gaut, J. P., Byun, J., Tran, H. D., Lauber, W. M., Carroll, J. A., Hotchkiss, R. S., Belaaouaj, A., & Heinecke, J. W. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15021 · Cited by 202
Smith, J. D., Miyata, M., Ginsberg, M., Grigaux, C., Shmookler, E., & Plump, A. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30647 · Cited by 197
Self-citationThukkani, A. K., McHowat, J., Hsu, F.-F., Brennan, M.-L., Hazen, S. L., & Ford, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000104564.01539.6a · Cited by 194
Self-citationNitric Oxide Reaction with Lipid Peroxyl Radicals Spares α-Tocopherol during Lipid Peroxidation
Rubbo, H., Radi, R., Anselmi, D., Kirk, M., Barnes, S., Butler, J., Eiserich, J. P., & Freeman, B. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10812 · Cited by 182
Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis
Heinecke, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03145-4 · Cited by 168
The Role of High-Density Lipoproteins in Oxidation and Inflammation
Van Lenten, B. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00095-0 · Cited by 165
Steinbrecher, U. P., & Lougheed, M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.5.608 · Cited by 153
Pecoits‐Filho, R., Stenvinkel, P., Marchlewska, A., Heimbürger, O., Barany, P. F., Hoff, C. M., Holmes, C. J., Suliman, M., Lindholm, B., Schalling, M., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.32.x · Cited by 126
Chen, W., Silver, D. L., Smith, J. D., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004552200 · Cited by 124
Self-citationMarsche, G., Hammer, A., Oskolkova, O., Kozarsky, K., Sattler, W., & Malle, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200503200 · Cited by 120
Prognostic Value of Myeloperoxidase in Patients With Chest Pain
Brennan, M., Penn, M. S., Lente, F. V., Nambi, V., Shishenbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000119182.52833.5e · Cited by 118
Self-citationOxidized lipids as mediators of coronary heart disease
Navab, M., Hama, S. Y., Ready, S. T., Ng, C. J., Lenten, B. J. V., Laks, H., & Fogelman, A. M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200208000-00003 · Cited by 110
Panzenboeck, U., Raitmayer, S., Reicher, H., Lindner, H., Glatter, O., Malle, E., & Sattler, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29711 · Cited by 103
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
Carr, A. C., Myzak, M. C., Stocker, R., McCall, M. R., & Frei, B. B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02227-4 · Cited by 102
Rakita, R. M., Michel, B. R., & Rosen, H. (1990) · Biochemistry · doi:10.1021/bi00456a033 · Cited by 86
Modification of proteins and lipids by myeloperoxidase
Hazen, S. L., Hsu, F., Gaut, J. P., Crowley, J. R., & Heinecke, J. W. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00117-2 · Cited by 85
Self-citationWever, R., Plat, H., & Hamers, M. N. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80320-1 · Cited by 83
Hazell, L., & Stocker, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01066-1 · Cited by 78
Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease
Asselbergs, F. W., Reynolds, W. F., Tervaert, J. W. C., Jessurun, G. A. J., & Tio, R. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.025 · Cited by 78
van der Leede, B. M., van den Brink, C. E., Pijnappel, W. W. M. P., Sonneveld, E., van der Saag, P. T., & van der Burg, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17921 · Cited by 76
Bergt, C., Marsche, G., Panzenboeck, U., Heinecke, J. W., Malle, E., & Sattler, W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02253.x · Cited by 75
Panzenboeck, U., Kritharides, L., Raftery, M. J., Rye, K., & Stocker, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000458200 · Cited by 74
Yang, C.-Y., Gu, Z., Yang, M., Lin, S., Garcia‐Prats, A. J., Rogers, L. K., Welty, S. E., & Smith, C. V. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32148-9 · Cited by 73
Identification of cAMP analogue inducible genes in RAW264 macrophages
Takahashi, Y., Miyata, M., Zheng, P., Imazato, T., Horwitz, A. A., & Smith, J. D. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00133-0 · Cited by 64
Self-citationWang, W.-Q., Merriam, D. L., Moses, A. S., & Francis, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17391 · Cited by 63
Site-Specific Quantitation of Protein Nitration Using Liquid Chromatography/Tandem Mass Spectrometry
Willard, B. B., Ruse, C. I., Keightley, J. A., Bond, M., & Kinter, M. T. (2003) · Analytical Chemistry · doi:10.1021/ac034033j · Cited by 61
Self-citationHazen, S. L., Gaut, J. P., Crowley, J. R., Hsu, F., & Heinecke, J. W. (2000) · Biochemical Journal · doi:10.1042/bj3520693 · Cited by 47
Self-citationHigh-Density Lipoprotein and the Dynamics of Atherosclerotic Lesions
Navab, M., Lenten, B. J. V., Reddy, S. T., & Fogelman, A. M. (2001) · Circulation · doi:10.1161/circ.104.20.2386 · Cited by 34
Lengths of truncated forms of apolipoprotein B (APOB) determine their intestinal production
Krul, E. S., Tang, J., Kettler, T. S., Clouse, R. E., & Schonfeld, G. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92313-m · Cited by 21
Effects of peroxynitrite on plasma components of the reverse cholesterol transport pathway
Graham, A., Vinogradov, D. V., & Owen, J. S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00785-6 · Cited by 10
Research works printed but not linked: 5
- Baldus, 2001, J. Clin. Invest., 108, 1759, 10.1172/JCI200112617 · DOI
- Gaut, 2002, J. Clin. Invest., 109, 1311, 10.1172/JCI0215021 · doi:10.1172/jci0215021 · Paper page
- Hazen, 2000, Biochem. J., 3, 693, 10.1042/0264-6021:3520693 · doi:10.1042/0264-6021:3520693
- Woods, 2001, J. Cell. Biochem. Suppl., 37, 89, 10.1002/jcb.10069 · doi:10.1002/jcb.10069
- Singaraja, 2002, J. Clin. Invest., 110, 35, 10.1172/JCI0215748 · doi:10.1172/jci0215748 · Paper page
Cited by
Biomarkers of Oxidative Damage in Human Disease
Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J.-C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 966
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Metadata
- Authors
- Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., Ischiropoulos, H., Smith, J. D., Kinter, M., & Hazen, S. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-08-16
- Volume
- 114
- Issue
- 4
- Pages
- 529-541
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107117207
- Cited by
- 737
- References
- 100
- FWCI
- 15.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.